Close

CLICK HERE to Nominate Your Jurisdiction for the Principles Award!

Menu
Contact Us

Resources and Updates

Blog

The Coalition of endorsing organizations is working in partnership to provide updates of what is happening with the litigation, related legislation, and state and local implementation strategies.

June 14, 2023

As states and jurisdictions begin to spend their dollars from the opioid litigation, what should they consider around naloxone distribution?

June 1, 2023

States and local jurisdictions are poised to receive more funds to help with opioid abatement as a result of a recent court decision in the Purdue Pharma bankruptcy.

May 18, 2023

Starting people with opioid use disorder on buprenorphine is one of the evidence-based strategies to reduce overdose deaths. What do new research studies tell us about how well we’re doing and where we need to be putting additional resources?

May 8, 2023

To take advantage full advantage of the opioid litigation dollars, state and communities need to invest in recovery services and implement social justice reforms.

April 25, 2023

Numerous organizations have endorsed the provisions of methadone, buprenorphine and naltrexone by jails and prisons. A new study examines whether, in addition to saving lives, this approach is also cost-effective.

April 11, 2023

Starting people on buprenorphine in the emergency department after they’ve had an overdose has been proven to save lives. Practice change is hard, though. A recent article evaluated what happened after one program in Pennsylvania tried to do just that.

April 4, 2023

Some pharmaceutical companies and distributors have offered medications to treat opioid use disorder and overdose reversal drugs as part of the opioid settlements with states, cities, and counties. What should jurisdictions consider before entering these agreements so they can take full advantage of them?

March 22, 2023

The increasing use of psychostimulants, including cocaine and methamphetamine), alone and together with fentanyl is viewed as the “fourth wave” of the overdose crisis. Contingency management is an essential intervention to assist individuals with stimulant use disorder.